Project Grant HT94252410527
Award Date
6/1/24
Completion Date
5/31/28
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
The Department of the Army Medical Command awarded a $1,724,662 Project Grant to the University of Wisconsin-Madison under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to identify neuronal signatures that distinguish Fragile X syndrome patients exhibiting distinct electroencephalogram phenotypes. The University of Wisconsin System, doing business as Research and Sponsored Programs, will perform the work over a four-year period ending July...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
The University of Wisconsin System was awarded a $1,199,999 Project Grant from the Department of the Navy's Office of Naval Research under the Basic and Applied Scientific Research program (CFDA 12.300). The grant, with a performance period from November 1, 2024 to October 31, 2028, will fund the development of a "Translational Injury Model System for Identifying Neuroimaging and Neural Signaling-Based Biomarkers for Early Detection and Mitigation of Mild Traumatic Brain Injury."...
This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
The University of Wisconsin System, through its University of Wisconsin - Madison division, was awarded a $599,997 Project Grant by the Department of Defense (DoD) under the Basic Scientific Research program (CFDA 12.431). The grant supports "OPERANDO VISUALIZATION AND MODELING OF DYNAMIC HETEROGENEITY AND COUPLED PHENOMENA IN INTERCALATION ELECTRODES" research from June 1, 2024 to May 31, 2027. This DoD-funded research project aims to advance fundamental knowledge and develop...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $155,500.00 to the University of Wisconsin - Madison to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The award period runs from December 1, 2024 to November 30, 2025. This grant supports innovative biomedical research focused on transforming healthcare for military service members and the...
The University of Wisconsin-Madison was awarded a $932,454 Project Grant from the Department of the Army Medical Command through the Military Medical Research and Development program. This three-year grant will support research into regulatory B cells and their potential to promote remyelination in a mouse model of multiple sclerosis. Specifically, the university researchers will define the role of Breg-responsive central nervous system-resident T cells in oligodendrogenesis. The work will be...
This $495,083 federal Project Grant award from the U.S. Department of Defense's Research, Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431) supports foundational and applied research across diverse scientific and technical domains critical to national security. The award was made to the University of Wisconsin System, with the University of Wisconsin-Madison as the primary performing entity, for the project period from October 1, 2024 to...
The University of Wisconsin System has been awarded a $492,040 Project Grant from the Department of the Navy, Office of Naval Research (CFDA 12.300 - Basic and Applied Scientific Research) to develop a finite element model for brain interface behavior. The 3-year project, which began on September 1, 2023 and is scheduled for completion by August 31, 2026, aims to advance naval research and operations through innovative basic and applied research in areas such as neural interfaces and modeling....
The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...